Akari Therapeutics Plc (AKTX) stock
AKTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 0/30
$6.65+0.95 (+16.67%)
Close on Nov 18, 2026Market cap $12.95MP/E –Yield –
Akari Therapeutics total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Akari Therapeutics's total debt was $200.00K at Sep 30, 2024.
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2024 | Sep 30, 2024 | $200.00K | – |
| Q2 FY2024 | Jun 30, 2024 | $600.00K | – |
| Q1 FY2024 | Mar 31, 2024 | $900.00K | – |
See a number that looks wrong?